Kidney cancer cases are projected to double by 2050
Lifestyle risk factors such as obesity, smoking, lack of exercise, [...]
Stoptober is back!
Because smoking is one of the main risk factors for [...]
Kidney cancer mutation found in 70% of Japanese patients
An international study involving 11 countries, including Japan, the United [...]
Risk for COVID-19 breakthrough infection increased for cancer patients
A recent study published in JAMA Oncology has shown that [...]
ASCO GU 2023: Adjuvant pembrolizumab for different risks and stages of kidney cancer
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
ASCO 2021: Baseline characteristics affect survival with nivolumab plus cabozantinib
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
New risk scoring system for metastatic kidney cancer
The treatment options for metastatic renal cell carcinoma (RCC) have [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
Real-world clinical outcomes with first-line sunitinib for metastatic kidney cancer
A paper published in The Oncologist last month analysed real-world [...]
Regular exercise reduces risk for 7 different cancers
A new study published in Journal of Clinical Oncology suggests [...]
